Limin Wu1, Mingyang Li1, Yi Zeng2, Haibo Si1, Yuan Liu1, Peng Yang1, Bin Shen3. 1. Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China. 2. Department of Orthopaedic Surgery and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. 3. Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, Sichuan, China. shenbin71@hotmail.com.
Abstract
PURPOSE: Opioids are a mainstay for pain management after total joint arthroplasty (TJA). The prevalence and risk factors for prolonged opioid use after TJA are important to understand to help slow the opioid epidemic. We aim to summarize and evaluate the prevalence and time trend of prolonged opioid use after TJA and pool its risk factors. METHODS: Following the preferred reporting items for systematic reviews and meta-analysis statement, we systematically searched PubMed, the Cochrane Library, and EMBASE, etc. from inception up to October 1, 2019. Cohort studies reporting risk factors for prolonged opioids use (≥ 3 months) after TJA were included. Studies characteristics, risk ratios (RR), and prevalence of prolonged opioid use were extracted and synthesized. RESULTS: A total of 15 studies were published between 2015 and 2019, with 416,321 patients included. 12% [95%CI 10-14%] of patients had prolonged opioid use after TJA and its time trend was associated with median enrollment years (P = 0.0013). Previous opioid use (RR = 1.73; P < 0.001), post-traumatic stress disorder (RR = 1.34; P < 0.001), benzodiazepine use (RR = 1.38; P < 0.001), tobacco abuse (RR = 1.26; P < 0.001), fibromyalgia (RR = 1.51; P < 0.001), and back pain (RR = 1.34; P < 0.001) were the largest effective risk factors for prolonged use of opioids. CONCLUSIONS: To our knowledge, this is the first meta-analysis determining the risk factors of prolonged opioid use and characterizing its rate and time trend in TJA. Understanding risk factors for patients with higher potential for prolonged opioids use can be used to implement appropriate management strategies, reduce unsafe opioid prescriptions, and decrease the risk of prolonged opioid use after TJA.
PURPOSE: Opioids are a mainstay for pain management after total joint arthroplasty (TJA). The prevalence and risk factors for prolonged opioid use after TJA are important to understand to help slow the opioid epidemic. We aim to summarize and evaluate the prevalence and time trend of prolonged opioid use after TJA and pool its risk factors. METHODS: Following the preferred reporting items for systematic reviews and meta-analysis statement, we systematically searched PubMed, the Cochrane Library, and EMBASE, etc. from inception up to October 1, 2019. Cohort studies reporting risk factors for prolonged opioids use (≥ 3 months) after TJA were included. Studies characteristics, risk ratios (RR), and prevalence of prolonged opioid use were extracted and synthesized. RESULTS: A total of 15 studies were published between 2015 and 2019, with 416,321 patients included. 12% [95%CI 10-14%] of patients had prolonged opioid use after TJA and its time trend was associated with median enrollment years (P = 0.0013). Previous opioid use (RR = 1.73; P < 0.001), post-traumatic stress disorder (RR = 1.34; P < 0.001), benzodiazepine use (RR = 1.38; P < 0.001), tobacco abuse (RR = 1.26; P < 0.001), fibromyalgia (RR = 1.51; P < 0.001), and back pain (RR = 1.34; P < 0.001) were the largest effective risk factors for prolonged use of opioids. CONCLUSIONS: To our knowledge, this is the first meta-analysis determining the risk factors of prolonged opioid use and characterizing its rate and time trend in TJA. Understanding risk factors for patients with higher potential for prolonged opioids use can be used to implement appropriate management strategies, reduce unsafe opioid prescriptions, and decrease the risk of prolonged opioid use after TJA.
Entities:
Keywords:
Long-term; Opioid; Prevalence; Prolonged; Risk factors; Total joint arthroplasty
Authors: Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March Journal: Ann Rheum Dis Date: 2014-02-19 Impact factor: 19.103
Authors: Kelvin Y Kim; Afshin A Anoushiravani; Kevin K Chen; Mackenzie Roof; William J Long; Ran Schwarzkopf Journal: J Arthroplasty Date: 2017-08-03 Impact factor: 4.757
Authors: Molly T Vogt; C Kent Kwoh; Doris K Cope; Thaddeus A Osial; Michael Culyba; Terence W Starz Journal: Spine (Phila Pa 1976) Date: 2005-05-01 Impact factor: 3.468
Authors: Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone Journal: Arthritis Rheum Date: 2008-01
Authors: Anita G Rao; Priscilla H Chan; Heather A Prentice; Elizabeth W Paxton; Ronald A Navarro; Mark T Dillon; Anshuman Singh Journal: J Shoulder Elbow Surg Date: 2018-06-08 Impact factor: 3.019
Authors: Jennifer M Hah; Yasamin Sharifzadeh; Bing M Wang; Matthew J Gillespie; Stuart B Goodman; Sean C Mackey; Ian R Carroll Journal: Pain Res Treat Date: 2015-12-31
Authors: Christian B Ong; Simarjeet Puri; Juliana Lebowitz; Yu-Fen Chiu; Alejandro Gonzalez Della Valle; Alexandra Sideris; Brian P Chalmers Journal: Arch Orthop Trauma Surg Date: 2022-09-21 Impact factor: 2.928
Authors: Edward C Beck; Benedict U Nwachukwu; Justin Drager; Kyleen Jan; Jonathan Rasio; Vignesh P Krishnamoorthy; Shane J Nho Journal: Orthop J Sports Med Date: 2021-11-29
Authors: Vishal Hegde; Daniel N Bracey; Roseann M Johnson; Yasmin Yazdani Farsad; Douglas A Dennis; Jason M Jennings Journal: Arthroplast Today Date: 2022-09-19
Authors: C Côté; M Bérubé; L Moore; F Lauzier; L Tremblay; E Belzile; M-O Martel; G Pagé; Y Beaulieu; A M Pinard; K Perreault; C Sirois; S Grzelak; A F Turgeon Journal: BMC Musculoskelet Disord Date: 2022-03-11 Impact factor: 2.362